Asenapine for elderly bipolar manic patients

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Bipolar disorder (BPD) in the elderly is probably heterogeneous and its etiopathogenesis is complex. The data for the treatment of late-life BPD are limited. Asenapine is approved in the United States for acute treatment of manic or mixed episodes of bipolar I disorder with or without psychotic features.

Related collections

Author and article information

Journal

Title: Journal of Affective Disorders

Abbreviated Title: Journal of Affective Disorders

Publisher: Elsevier BV

ISSN (Print): 01650327

Publication date Created: February 2013

Publication date (Print): February 2013

Volume: 145

Issue: 1

Pages: 130-132

Article

DOI: 10.1016/j.jad.2012.05.027

PubMed ID: 22877962

SO-VID: 8485450b-7d21-427a-8bea-337b4e070441

License:

http://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.